Company Overview
- Headquarters
- 2464 Massachusetts Ave Ste 314, Cambridge MA
- Website
- alkeuspharma.com
- in****@alkeus.com
- Phone
- (800) 287-****
- Employees
- 1
- Founded in
- 2010
- Industry
- BioTech/Drugs
- NAICS Code
- 325, 32, 32541, 3254
- SIC Code
- 28, 283
Financials & Stats
Revenue
$5B
Who is Alkeus Pharmaceuticals Inc
Alkeus Pharmaceuticals Inc. is a late-stage biopharmaceutical company based in Cambridge, Massachusetts. The company employs 1 person and reports $5.4 million in annual revenue. Alkeus Pharmaceuticals focuses on developing transformative therapeutics for serious, progressive eye diseases that can lead to blindness. Their lead compound, ALK-001, is an oral investigational drug being developed for the treatment of Stargardt disease (STGD) and Geographic Atrophy (GA) secondary to dry age-related macular degeneration. ALK-001 is a selectively-deuterated form of Vitamin A that slows the dimerization of Vitamin A, which is implicated in STGD. This compound has demonstrated statistically-significant and clinically-meaningful efficacy in the TEASE-1 Phase 2 clinical trial, leading to Breakthrough Therapy Designation for the treatment of Stargardt Disease. For more information about Alkeus Pharmaceuticals Inc., please visit their website at alkeuspharma.com.
Company Leadership
Alkeus Pharmaceuticals Inc Tech Stack
Companies Similar to Alkeus Pharmaceuticals Inc
Analyze industry trends and opportunities by examining competitors and companies comparable to Alkeus Pharmaceuticals Inc, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 5M | 30 | Woodinville, WA | ||
| 5M | 25 | Chicopee, MA | 2018 | |
| 5M | 10 | New York, NY | 1973 | |
| 5M | 5 | Sparks, MD | 1999 | |
| 5M | 7 | San Diego, CA | 2011 |